H. T. Kim
1 Papers
H. T. Kim is an academic researcher. The author has contributed to research in topics: Lung cancer & Pemetrexed. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Maintenance bevacizumab–pemetrexed after first-line cisplatin–pemetrexed–bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial
Fabrice Barlesi,Arnaud Scherpereel,Vera Gorbunova,Radj Gervais,Anders Vikström,Christos Chouaid,Antonio Chella,Jeong-Ho Kim,Myung-Ju Ahn,Martin Reck,Antonio Pazzola,H. T. Kim,Joachim G.J.V. Aerts,Claire Morando,Anderson Loundou,H. Groen,Achim Rittmeyer +16 more
TL;DR: In an unselected population of nsNSCLC patients achieving disease control on platinum-based induction therapy, maintenance with bevacizumab-pemetrexed was associated with a nonsignificant increase in OS over bevacsumab alone.
172